CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Larrea Biosciences Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Larrea Biosciences Corp
1628 Marshall
Phone: (832) 695-0096p:832 695-0096 HOUSTON, TX  77006  United States Fax: (832) 285-1307f:832 285-1307
On 11/4/2013, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of Larrea Biosciences Corp for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.
Business Summary
Larrea Biosciences Corporation (Larrea), focuses on manufacturing, licensing and distributing Green dietary supplement.The Company's products are derived from the desert shrub Larrea tridentata. The extract from this plant, Larreastatin, is the key ingredient in all of the Company's products, which are sold under the trade names LarreaRx and Shegoi. The Company's capsules, lotion and topical spray are sold by the Company through retail channels and direct marketing programs under the names of Shegoi and LarreaRx.
(Source: 10KSB)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
1/31/20084/30/2007YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Financial Officer, Director Gary D.Woerz 66 8/18/2008 8/18/2008
Chief Executive Officer, Director Peter P.Smetek 67 8/18/2008 1/1/2004
Director RichardAscione 8/18/2008 8/18/2008
Director DennisClark 8/18/2008 8/18/2008
Director ShengmeiQi 8/18/2008 8/18/2008

Business Names
Business Name
Global Botanics, Inc.
LARREA BIOSCIENCES CORP
Larrea Biosciences Corporation
LarreaRx Strategies, Inc.
LarreaRx, Inc.
SONIC MEDIA CORP

General Information
Number of Employees: 1 (As of 4/30/2007)
Outstanding Shares: 30,571,945 (As of 1/31/2008)
Shareholders: 69
Stock Exchange: OTC
Federal Tax Id: 680507505
Fax Number: (832) 285-1307


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023